NasdaqGS - Delayed Quote USD

Inari Medical, Inc. (NARI)

38.42 +0.35 (+0.92%)
At close: April 26 at 4:00 PM EDT
36.90 -1.52 (-3.96%)
After hours: April 26 at 5:29 PM EDT

Key Executives

Amounts are as of December 31, 2023 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.
NameTitlePayExercisedYear Born
Mr. Andrew J. Hykes CEO, President & Director 1.54M -- 1973
Mr. Mitchell C. Hill Chief Financial Officer 864.63k 4.78M 1959
Dr. Thomas M. Tu M.D. Chief Medical Officer 865.63k 1.17M 1973
Mr. Paul A. Koehn Senior Vice President of Operations -- -- 1963
Mr. Kevin Strange Senior Vice President of Finance, Accounting, Strategy & Business Development -- -- --
Mr. John Hsu C.F.A. Vice President of Investor Relations -- -- --
Ms. Angela Ahmad General Counsel & Secretary -- -- --
Mr. Eric Khairy Senior Vice President of Marketing -- -- --
Mr. Tim Benner Senior VP of Sales & Senior VP of U.S. Sales -- -- --
Ms. Tara Dunn Senior VP & GM of LimFlow -- -- --

Inari Medical, Inc.

6001 Oak Canyon
Suite 100
Irvine, CA 92618
United States
877 923 4747 https://www.inarimedical.com
Sector: 
Healthcare
Industry: 
Medical Devices
Full Time Employees: 
1,300

Description

Inari Medical, Inc. builds minimally invasive, novel, and catheter-based mechanical thrombectomy devices and accessories for the specific disease states in the United States. The company provides ClotTriever system, which is designed to core, capture, and remove large clots from large vessels for treatment of deep vein thrombosis and peripheral thrombus; FlowTriever system, a large bore catheter-based aspiration and mechanical thrombectomy system to remove large clots from large vessels in the peripheral vasculature for treating pulmonary embolism and other complex venous thromboembolism cases; InThrill system to treat small vessel thrombosis; and LimFlow system for patients who have chronic limb-threatening ischemia with no suitable endovascular or surgical revascularization options and risk of major amputation. It serves interventional radiologists, interventional cardiologists, and vascular surgeons. The company was formerly known as Inceptus Newco1 Inc. and changed its name to Inari Medical, Inc. in September 2013. Inari Medical, Inc. was incorporated in 2011 and is headquartered in Irvine, California.

Corporate Governance

Inari Medical, Inc.’s ISS Governance QualityScore as of April 1, 2024 is 5. The pillar scores are Audit: 2; Board: 5; Shareholder Rights: 8; Compensation: 6.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Recent Events

Upcoming Events

Apr 30, 2024
Inari Medical, Inc. Earnings Call

Related Tickers